Schoenherr advised the underwriters Leerink Partners LLC, RBC Capital Markets LLC, Needham & Company and Wedbush PacGrow as to Austrian law on Vienna-based Nabriva Therapeutics’ initial public offering in the US and its listing on NASDAQ.
The transaction was structured such that American Depositary Shares, each representing one-tenth of Nabriva’s underlying registered shares, were offered in the US.
The Schoenherr team consisted of partners Ursula Rath (Capital Markets) and Christian Herbst (Corporate/M&A) and attorney Hutan Rahmani (Capital Markets). Partners Eric Blanchard and Brian Rosenzweig of the New York office of Covington & Burling acted as the underwriters’ international counsel.
